Literature DB >> 24108096

Tumour microenvironment: Teaching old macrophages new tricks.

Sarah Seton-Rogers.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24108096     DOI： 10.1038/nrc3616

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression.

Authors:  Stephanie M Pyonteck; Leila Akkari; Alberto J Schuhmacher; Robert L Bowman; Lisa Sevenich; Daniela F Quail; Oakley C Olson; Marsha L Quick; Jason T Huse; Virginia Teijeiro; Manu Setty; Christina S Leslie; Yoko Oei; Alicia Pedraza; Jianan Zhang; Cameron W Brennan; James C Sutton; Eric C Holland; Dylan Daniel; Johanna A Joyce
Journal:  Nat Med       Date:  2013-09-22       Impact factor: 53.440
  1 in total
  5 in total

1.  FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

Authors:  Jun Yan; Ling-Yuan Kong; Jiemiao Hu; Konrad Gabrusiewicz; Denada Dibra; Xueqing Xia; Amy B Heimberger; Shulin Li
Journal:  J Natl Cancer Inst       Date:  2015-05-13       Impact factor: 13.506

2.  Involvement of Aryl Hydrocarbon Receptor in L-Kynurenine-Mediated Parathyroid Hormone-Related Peptide Expression.

Authors:  Zhiqing Duan; Jiangong Lu
Journal:  Horm Cancer       Date:  2019-01-28       Impact factor: 3.869

3.  Tumor suppressive role of miR-194-5p in glioblastoma multiforme.

Authors:  Zhao Zhang; Bo Lei; Honggang Wu; Xiaoli Zhang; Niandong Zheng
Journal:  Mol Med Rep       Date:  2017-10-19       Impact factor: 2.952

Review 4.  Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis.

Authors:  Salvatore J Coniglio
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-07       Impact factor: 5.555

5.  Identification of a competing endogenous RNA axis "SVIL-AS1/miR-103a/ICE1" associated with chemoresistance in lung adenocarcinoma by comprehensive bioinformatics analysis.

Authors:  Lili Guo; Lina Ding; Junfang Tang
Journal:  Cancer Med       Date:  2021-07-15       Impact factor: 4.452
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.